| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/23/2009 | CN101537059A Anti-enteritis canine parvovirus Chinese medicinal composition and preparation method and applications thereof |
| 09/23/2009 | CN101537053A Novel use of Chinese herbal medicines like papaya, achyranthes and angelica for treating poliomyelitis sequela by utilizing |
| 09/23/2009 | CN101537047A Novel use of Chinese herbal medicines like honeysuckle flower, forsythia, peppermint and scutellaria for treating poliomyelitis sequela |
| 09/23/2009 | CN101537045A Novel use of Chinese herbal medicines like mulberry twigs, angelica and safflower for treating poliomyelitis sequela |
| 09/23/2009 | CN101537043A Novel use of Chinese herbal medicines like raw astragalus, angelica, cassia twig and achyranthes for treating poliomyelitis sequelae |
| 09/23/2009 | CN101537041A Chinese medicinal composition for treating hepatitis A and hepatitis B |
| 09/23/2009 | CN101537038A Pharmaceutical composition for preventing and curing children cold and preparation method thereof |
| 09/23/2009 | CN101537025A Preparation method for increasing content of total saponin, low polarity saponin and argininyl fructosy glucose in red ginseng |
| 09/23/2009 | CN101537017A Novel application of meat skins of domestic animals in the field of medicaments |
| 09/23/2009 | CN101537009A Production process of compound preparation of ceftriaxone sodium and tazobactam sodium for injection |
| 09/23/2009 | CN101537008A Livestock cefquinome bletilla striata bioadhesive slow-release capsules |
| 09/23/2009 | CN101537004A Pubes-cleaning disinfection nursing liquid used for pudendum and vagina of human body |
| 09/23/2009 | CN101537000A Multi-purpose disinfectant |
| 09/23/2009 | CN101536998A Composition used for treating AIDS and associated diseases and preparation method thereof |
| 09/23/2009 | CN101536992A Livestock cefquinome colon-targeted pills and preparation method thereof |
| 09/23/2009 | CN101536985A Livestock cefquinome lung-targeted microspheres and preparation method thereof |
| 09/23/2009 | CN101536968A Cellular fluid of fresh flowers of roses and preparation method thereof |
| 09/23/2009 | CN101536854A Health-caring process quilt |
| 09/23/2009 | CN101536716A Health preserving and protecting tea with auxiliary curative effect on wind-heat type cold and preparation method thereof |
| 09/23/2009 | CN100543032C Streptogramin derivatives, preparation and compositions containing them |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542610C Solution for ungual and peri-ungual and its application in preparing medicine for mycosis |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/23/2009 | CN100542535C Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592368 HIV aspartyl protease inhibitors; solubility, bioavailability; viral and HIV infections |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592316 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/22/2009 | US7592310 Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
| 09/22/2009 | US7592140 2′, 5′-oligoadenylate phosphodiesterase |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2474627C R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1h-imidazole |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2396720C Thiazolyl amide derivatives |
| 09/22/2009 | CA2223703C Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 09/17/2009 | WO2009114810A2 Use of ellagitannins as inhibitors of bacterial quorum sensing |
| 09/17/2009 | WO2009114623A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | WO2009114153A1 Oligomer-foscarnet conjugates |
| 09/17/2009 | WO2009114151A1 Oligomer-amino acid and olgomer-atazanavir conjugates |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113661A1 Cyclic compound and salt thereof |
| 09/17/2009 | WO2009113560A1 Fused heterocyclic compound |
| 09/17/2009 | WO2009113542A1 HBs-PEPTIDE CONJUGATE |
| 09/17/2009 | WO2009113464A1 Anti-influenza virus composition and food for preventing influenza |
| 09/17/2009 | WO2009113438A1 Antibacterial composition for medical use and medical device |
| 09/17/2009 | WO2009113435A1 Sugar derivative preparation |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113404A1 Inhibitor for growth of bacteria of genus legionella, bath agent and cleaning agent |
| 09/17/2009 | WO2009113403A1 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent |
| 09/17/2009 | WO2009113033A2 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 09/17/2009 | WO2009111838A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | WO2009111830A1 Conjugated unsaturated compounds |
| 09/17/2009 | WO2009089070A9 Compositions and methods for reducing particle penetration through mucus |
| 09/17/2009 | WO2009080836A3 Macrocyclic indoles as hepatitis c virus inhibitors |
| 09/17/2009 | WO2009079452A3 Treatment and prevention of hiv infection |
| 09/17/2009 | WO2009055799A3 Compositions and methods for treatment of diseases of the foot of an animal |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | WO2003007876A3 N-fatty acid-amino acid conjugates and therapeutic uses |
| 09/17/2009 | US20090234023 Substituted hydroxyacetophenone derivatives |
| 09/17/2009 | US20090233992 Hepatitis c virus vaccine |
| 09/17/2009 | US20090233985 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 09/17/2009 | US20090233925 Hepatitis C Virus Inhibitors |
| 09/17/2009 | US20090233914 Composition for treatment of nail infections |
| 09/17/2009 | US20090233895 Method of treatment of bacterial infections |
| 09/17/2009 | US20090233884 Use of cyclipostin derivatives for the treatment of mycobacterial infectious diseases |
| 09/17/2009 | US20090233879 Novel nucleoside derivatives |
| 09/17/2009 | US20090233867 Treatment of ocular wounds and ulcers |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090232894 Process for Stabilizing an Adjuvant Containing Vaccine Composition |
| 09/17/2009 | US20090232888 Sustained delivery of antibiotics |
| 09/17/2009 | US20090232848 Methods for cultivating lawsonia intracellularis |
| 09/17/2009 | US20090232847 Immunogenic compositions |
| 09/17/2009 | US20090232844 Immunopotentiating compounds |
| 09/17/2009 | US20090232843 Identifying and predicting influenza variants and uses thereof |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232798 Methods and compositions for treating herpes infections |
| 09/17/2009 | US20090232769 Pharmaceutical Composition For Treatment Of Blood Clotting Disorder |
| 09/17/2009 | US20090232766 Compositions for Inducing Immune Response Comprising Inverted Microsomes |
| 09/17/2009 | US20090232749 Compositions for the acute and/or long term treatment of periodontal diseases |
| 09/17/2009 | US20090232748 Virucidal activities of cetylpyridinium chloride |
| 09/17/2009 | DE102008014077A1 New borrelidin derivatives are janus kinase 3 inhibitors useful e.g. for treating tumor, microbial infection, immune disorder and ophthalmic disease, inhibiting angiogenesis, and manufacturing herbicides and insecticides against arthropods |
| 09/17/2009 | CA2718395A1 Cyclic compound and salt thereof |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2718237A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | CA2718175A1 Use of 4'-thio-2'-deoxynucleosides as anti orthopoxvirus agents |
| 09/17/2009 | CA2718153A1 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100955A2 Attenuated mutants of human parainfluenza virus type 1 (HPIV1) |
| 09/16/2009 | EP2100893A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 09/16/2009 | EP2100890A1 Novel polynitrogenated systems as anti-hiv agents |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2100616A2 Composition of antigen and glycolipid adjuvant sublingual administration |
| 09/16/2009 | EP2100602A1 Method and compositions suitable for treatment of wounds |